![Emanuele Marra](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Emanuele Marra currently works as a Chief Operating Officer at Takis Srl.
Emanuele Marra active positions
Companies | Position | Start |
---|---|---|
Takis SRL
![]() Takis SRL BiotechnologyHealth Technology Takis Srl is an Italian biotech company founded in November 2009 by a group of scientists from IRBM, a research center near Rome, Italy. Takis is based in Castel Romano, IT and has more than 10 years of experience in drug discovery, contributing to the validation of new targets for the treatment of chronic viral diseases and cancer, and to a number of IND/CSA filings in the areas of virology and oncology. The private company specializes in drug discovery in oncology and has expertise in vivo electro-gene-transfer, which can be used for a variety of clinically useful applications, from vaccine development to somatic gene therapy. Takis' pipeline includes four cancer vaccine candidates based on this technology. The company was founded by Luigi Aurisicchio, who has been the CEO since incorporation. | Chief Operating Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Takis SRL
![]() Takis SRL BiotechnologyHealth Technology Takis Srl is an Italian biotech company founded in November 2009 by a group of scientists from IRBM, a research center near Rome, Italy. Takis is based in Castel Romano, IT and has more than 10 years of experience in drug discovery, contributing to the validation of new targets for the treatment of chronic viral diseases and cancer, and to a number of IND/CSA filings in the areas of virology and oncology. The private company specializes in drug discovery in oncology and has expertise in vivo electro-gene-transfer, which can be used for a variety of clinically useful applications, from vaccine development to somatic gene therapy. Takis' pipeline includes four cancer vaccine candidates based on this technology. The company was founded by Luigi Aurisicchio, who has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Emanuele Marra